Continuum of

Progress

A main actor in pharmaceutical synthesis and specialty ingredients

A leader in pharmaceutical synthesis

Offering a wide range of technologies, Seqens provide its clients custom manufacturing services as well as a large portfolio of APIs & intermediates. We offer our customers with an access to our network of 3 R&D centers, 4 pilot units and 12 cGMP manufacturing sites and 6 cGMP multi-purposes sites to ensure a smooth in-house scale-up from early clinical phases to the commercial stage.

Discover

A cross-functional knowledge in specialty ingredients

Seqens offers a wide continuum of technologies covering small-scale to large-scale chemical synthesis and distillation including distinctive reactions such as Fiedel-Craft, Grignard and low-metal capabilities. This industrial network is supported by focused R&D capabilities. Seqens offers high purity oxygenated solvents leveraging its back-integrationl and a large range of Minerals Specialties produced.

Discover

A large expertise
in cosmetics

Seqens has built a wide, comprehensive and cutting edge offer for the cosmetic market sourced in pharmaceutics and fine chemistry know-hows.

Discover

A continuum of technologies

SEQENS operates 24 industrial plants and 3 R&D centers in Europe, North America and Asia.

More than 300 scientists, engineers and experts develop tailor-made solutions for its customers and ensure that products are successfully transferred into production.

Newsroom

#Live

General

Seqens CDMO Wins Big at 2019 Life Science Leader Magazine CMO Leadership Awards “Top Performer” in 13 categories

Seqens CDMO announced that it has won six additional 2019 Life Science Leader CMO Leadership Awards that were handed out at the awards dinner held…
General

Seqens meets Frances Arnold at DCAT

SEQENS was honored to meet Frances Arnold, 2018 Chimistry Nobel Prize, at DCAT for a Keynote conference.
General

GenEvolution: awarded at the "Entrepreneur Prize" trophies of the Grand Paris Seine & Oise

On the evening of Tuesday, March 19, 2019, GenEvolution, based at the Porcheville Seqens site, received two awards: the Public Prize and the Innovation Prize.

Seqens global presence

Use interactive map
0

Employees

0

Scientists, experts and engineers

0

Manufacturing sites

0

Customers in more than 80 countries